Tagesspiegel.de highlights, in an article, our success in winning a challenge by the SPRIND agency of the Federal Ministry of Education and Research of Germany, and introduces the unique mechanism of action of our nasal spray currently in development. This nasal spray presents a novel approach in the creation of antiviral agents. With a significant audience of 9.2 million unique user per month, tagesspiegel.de represents one of the biggest news outlets in Germany. Stemming from a regional printed Newspaper, it is traditionally strong in the Berlin region, the German capital.
